Activation of protein kinase C-ζ and phosphatidylinositol 3'-kinase and promotion of macrophage differentiation by insulin-like growth factor-I

Journal of Immunology

Volumn 160, Issue 3, 1998, Pages 1393-1401

  Liu, Qiang ^a   Ning, Wei ^a   Dantzer, Robert ^c   Freund, Gregory G ^b   Kelley, Keith W ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

^c CEMAGREF   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; COLECALCIFEROL; MONOCLONAL ANTIBODY; PHOSPHATIDYLINOSITIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C; SOMATOMEDIN C;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRAIN HL 60; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME POLYMORPHISM; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANTIBODIES, BLOCKING; CELL COUNT; CELL DIFFERENTIATION; CELL SURVIVAL; CHOLECALCIFEROL; ENZYME ACTIVATION; FETAL BLOOD; HL-60 CELLS; HUMANS; INSULIN-LIKE GROWTH FACTOR I; ISOENZYMES; MACROPHAGE-1 ANTIGEN; MACROPHAGES; PHOSPHOTYROSINE; PRECIPITIN TESTS; PROTEIN KINASE C; RECEPTOR, IGF TYPE 1;

EID: 0031893929     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. Nishizuka, Y. 1992. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258:607.
2. Hug, H., and T. F. Sarre. 1993. Protein kinase C isoenzyrnes: divergence in signal transduction? Biochem. J. 291:129.
3. Ways, D. K., K. Posekany, J. deVente, T. Garris, J. Chen, J. Hooker, W. Qin, P. Cook, D. Fletcher, and P. Parker. 1994. Overexpression of protein kinase C-ζ stimulates leukemic cell differentiation. Cell Growth Differ. 5:1195.
4. Lacasa, D., B. Agli, and Y. Giudicelli. 1995. Zeta PKC in rat preadipocytes: modulation by insulin and serum mitogenic factors and possible role in adipogenesis. Biochem. Biophys. Res. Commun. 217:123.
5. Diaz-Meco, M. T., J. Lozano, M. M. Municio, E. Berra, S. Frutos, L. Sanz, and J. Moscat. 1994. Evidence of the in vitro and in vivo interaction of Ras with protein kinase C zeta. J. Biol. Chem. 269:31706.
6. Nakanishi, H., K. A. Brewer, and J. H. Exton. 1993. Activation of the zeta isozyme of protein kinase C by phosphatidylinositol 3,4,5-triphosphate. J. Biol. Chem. 268:13.
7. Cai, Y. C., D. Cefai, H. Schneider, M. Raab, N. Nabavi, and C. E. Rudd. 1995. Selective CD28pYMNM mutations implicate phosphatidylinositol 3-kinase in CD86-CD28-mediated costimulation. Immunity 3:417.
8. Yao, R., and G. M. Cooper. 1995. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science 267:2003.
9. Minshall, C., S. Arkins, G. G. Freund, and K. W. Kelley. 1996. Requirement for phosphatidylinositol 3′-kinase to protect hemopoietic progenitors against apoptosis depends upon the extracellular survival factor. J. Immunol. 156:939.
10. Rodriguez-Tarduchy, G., M. K. L. Collins, I. Garcia, and A. Lopez-Rivas. 1992. Insulin-like growth factor-I inhibits apoptosis in hemopoietic cells. J. Immunol. 149:535.
11. Párrizas, M., A. R. Saltiel, and D. LeRoith. 1997. Insulin-like growth factor 1 inhibits apoptosis using the phosphatidylinositol 3′-kinase and mitogen-activated protein kinase pathways. J. Biol. Chem. 272:154.
12. Dudek, H., S. R. Datta, T. F. Franke, M. J. Birnbaum, R. Yao, G. M. Copper, R. A. Segal, D. R. Kaplan, and M. E. Greenberg. 1997. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 275:661.
13. Aagaard-Tillery, K. M., and D. F. Jelinek. 1996. Phosphatidylinositol 3-kinase activation in normal human B lymphocytes. J. Immunol. 156:4543.
14. Kaliman, P., F. Vinals, X. Testar, M. Palacin, and A. Zorzano. 1996. Phosphatidylinositol 3-kinase inhibitors block differentiation of skeletal muscle cells. J. Biol. Chem. 271:19146.
15. Blalock, J. E. 1994. The syntax of immune neuroendocrine communication. Immunol. Today 15:504.
16. Kooijman, R., E. L. Hooghe-Peters, and R. Hooghe. 1996. Prolactin, growth hormone and insulin-like growth faclor-I in the immune system. Adv. Immunol. 63:377.
17. Arkins, S., N. Rebeiz, D. L. Brunke-Reese, C. Minshall, and K. W. Kelley. 1995. The colony-stimulating factors induce expression of insulin-like growth factor-I messenger ribonucleic acid during hematopoiesis. Endocrinology 136:1153.
18. Lake, F. R., P. W. Noble, P. W. Henson, and D. W. H. Riches. 1994. Functional switching of macrophage responses to tumor necrosis factor-α (TNF-α) by interferons: implications for the pleiotropic activities of TNF-α. J. Clin. Invest. 93:1661.
19. Weigent, D. A., and J. E. Blalock. 1995. Association between the neuroendocrine and immune systems. J. Leukocyte Biol. 58:137.
20. Merchav, S., I. Tatarsky, and Z. Hochberg. 1988. Enhancement of human granulopoiesis in vitro by biosynthetic insulin-like growth factor-I/somatomedin C and human growth hormone. J. Clin. Invest. 81:791.
21. Merchav, S., M. Lake, and A. Skottner. 1993. Comparative studies of the granulopoietic enhancing effects of biosynthetic human insulin-like growth factors I and II. J. Cell. Physiol. 157:178.
22. Landreth, K. S., R. Narayanan, and K. Dorshkind. 1992. Insulin-like growth factor-I regulates pro-B cell differentiation. Blood 80:1207.
23. Gibson, L. F., D. Piktel, and K. S. Landreth. 1993. Insulin-like growth factor-I potentiates expansion of interleukin-7-dependent pro-B cells. Blood 82:3005.
24. Li, Y. M., D. H. Schacher, Q. Liu, S. Arkins, N. Rebeiz, R. H. McCusker, Jr., R. Dantzer, and K. W. Kelley. 1997. Regulation of myeloid growth and differentiation by the insulin-like growth factor-I receptor. Endocrinology 138:362.
25. Collins, S. J. 1987. The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression. Blood 70:1233.
26. 3: comparison with the maturation of normal monocytic and granulocytic bone marrow cells. J. Leukocyte Biol. 58:547.
27. 3 and the effect of interferon γ. J. Leukocyte Biol. 54:40.
28. Darzynkiewicz, Z., X. Li, and J. Gong. 1994. Assays of cell viability: discrimination of cells dying by apoptosis. In Flow Cytometry, Vol. 41. Z. Darzynkiewicz, J. P. Robinson, and H. A. Crissman, eds. Bios Scientific, p. 16.
29. Folli, F., M. J. A. Saad, J. M. Backer, and C. R. Kahn. 1992. Insulin stimulation of phosphatidylinositol 3-kinase activity and association with insulin receptor substrate 1 in liver and muscle of the intact rat. J. Biol. Chem. 267:22171.
30. Kelly, K. L., and N. B. Ruderman. 1993. Insulin-stimulated phosphatidylinositol 3-kinase: association with a 185-kDa tyrosine-phosphorylated protein (IRS-1) and localization in a low density membrane vesicle. J. Biol. Chem. 268:4391.
31. Vlahos, C., W. F. Matter, R. F. Brown, A. E. Traynor-Kaplan, P. G. Heyworth, E. R. Prossnitz, R. D. Ye, P. Marder, J. A. Schelm, K. J. Rothfuss, B. S. Serlin, and P. J. Simpson. 1995. Investigation of neutrophil signal transduction using a specific inhibitor of phosphatidylinositol 3-kinase. J. Immunol. 154:2413.
32. SAS Institute. 1989. SAS/STAT User's Guide, Version 6, Vol. 2, 4th Ed. SAS Institute, Cary, NC.
33. Aaronson, S. A. 1991. Growth factor and cancer. Science 254:1146.
34. Rosenthal, S. M., and Z. Q. Cheng. 1995. Opposing early and late effects of insulin-like growth factor-I on differentiation and cell cycle regulatory retino-blastoma protein in skeletal myoblasts. Proc. Natl. Acad. Sci. USA 92:10307.
35. Pahlman, S., G. Meyerson, E. Lindgren, M. Schalling, and I. Johansson. 1991. Insulin-like growth factor I shifts from promoting cell division to potentiating maturation during neuronal differentiation. Proc. Natl. Acad. Sci. USA 88:9994.
36. Lund-Johansen, F., and L. W. M. M. Terstappen. 1993. Differential surface expression of cell adhesion molecules during granulocyte maturation. J. Leukocyte Biol. 54:47.
37. Antal-Szalmas, P., J. A. G. V. Strijp, A. J. L. Weersink, J. Verhoef, and K. P. M. V. Kessel. 1997. Quandtationof surface CD14 on human monocytes and neutrophils. J. Leukocyte Biol. 61:721.
38. Li, C. Y., K. W. Lam, and L. T. Lam. 1973. Esterase in human leukocytes. J. Histochem. Cytochem. 21:1.
39. Fairbaim, L. J., G. L. Cowling, B. M. Reipert, and T. M. Dexter. 1993. Suppression of apoptosis allows differentiation and development of a multipotent hemopoietic cell line in the absence of added growth factors. Cell 74:823.
40. Burgering, B. M., and P. J. Coffer. 1995. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 376:599.
41. Nissley, P., and W. Lopaczynski. 1991. Insulin-like growth factor receptors. Growth Factors 5:29.
42. Kull, F. C., S. Jacobs, Y.-F. Su, M. E. Svoboda, J. J. V. Wyk, and P. Cuatrecasas. 1982. Monoclonal antibodies to receptors for insulin and somatomedin-C. J. Biol. Chem. 258:6561.
43. Thissen, J.-P., J.-M. Ketelslegers, and L. E. Underwood. 1994. Nutritional regulation of insulin-like growth factors. Endocr. Rev. 15:80.
44. Roldan, A., E. Charreau, and R. Schillaci. 1989. Insulin-like growth factor-I increases the mitogenic response of human peripheral blood lymphocytes to phytohemagglutinin. Immunol. Lett. 20:5.
45. Bennett, M. R., G. I. Evan, and S. M. Schwartz. 1995. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J. Clin. Invest. 95:2266.
46. Conover, C. A., and D. R. Powell. 1991. Insulin-like growth factor (IGF) binding protein-3 blocks IGF-I-induced receptor down-regulation and cell densitization in cultured bovine fibroblasts. Endocrinology 129:710.
47. L. J. Biol. Chem. 271:17601.
48. Okada, T., L. Sakuma, Y. Fukui, O. Hazeki, and M. Ui. 1994. Blockage of chemotactic peptide-induced stimulation of neutrophils by wortmannin as result of selective inhibition of phosphatidylinositol 3-kinase. J. Biol. Chem. 269:3563.
49. Vlahos, C. J., W. F. Matter, K. Y. Hui, and R. F. Brown. 1994. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 269:5241.
50. Coleman, E. S., and M. W. Woolen. 1994. Nerve growth factor-induced differentiation of PC 12 cells employs the PMA-insensitive protein kinase C-ζ isoform. J. Mol. Neurosci. 5:39.
51. Kauffmann-Zeh, A., P. Rodriguez-Viciana, E. Ulrich, C. Gilbert, P. Coffer, J. Downward, and G. Evan. 1997. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature 385:544.
52. Crompton, T., K. C. Gilmour, and M. J. Owen. 1996. The MAP kinase pathway controls differentiation from double-negative to double-positive thymocyte. Cell 86:243.
53. Wang, X. Z., and D. Ron. 1996. Stress-induced phosphorylation and activation of the transcription factor CHOP by p38 MAP kinase. Science 272:1347.
54. Lechner, C., M. A. Zahalka, J. F. Giot, N. P. Moller, and A. Ullrich. 1996. Erk6, a mitogen-activated protein kinase involved in C2C12 myoblast differentiation. Proc. Natl. Acad. Sci. USA 93:4355.
55. Kieser, A., T. Seitz, H. S. Adler, P. Coffer, E. Kremmer, P. Crespo, J. S. Gutkind, D. W. Henderson, J. F. Mushinski, and W. Kolch. 1996. Protein kinase C-zeta reverts v-raf transformation of NIH-3T3 cells. Genes Dev. 10:1455.
56. Abraham, R. T. 1996. Phosphatidylinositol 3-kinase related kinases. Curr. Opin. Immunol. 8:412.
57. Brunn, G. J., J. Williams, C. Sabers, G. Wiederrecht, J. C. Lawrence, Jr., and R. T. Abraham. 1996. Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002. EMBO J. 15:5256.
58. Hartley, K. O., D. Gell, G. C. Smith, H. Zhang, N. Divecha, M. A. Connelly, A. Admon, S. P. Lees-Miller, C. W. Anderson, and S. P. Jackson. 1995. DNA-dependent protein kinase catalytic subunit: a relative of phosphatidylinositol 3-kinase and the ataxia telangiectasia gene product. Cell 82:849.
59. Cross, D. A., D. R. Alessi, J. R. Vandeheede, H. E. MacDowell, H. S. Hundal, and P. Cohen. 1994. The inhibition of glycogen synthase kinase-3 by insulin or insulin-like growth factor 1 in the rat skeletal muscle cell line L6 is blocked by wortmannin, but not by rapamycin. Biochem. J. 303:21.
60. Yano, H., T. Agatsuma, S. Nakanishi, Y. Saitoh, Y. Fukui, Y. Nonomura, and Y. Matsuda. 1995. Biochemical and pharmacological studies with KT7692 and LY294002 on the role of phosphatidylinositol 3-kinase in Fc epsilon RI-mediated signal transduction. Biochem. J. 312:145.
61. Baserga, R. 1994. Oncogenes and the strategy of growth factors. Cell 79:927.
62. Smith, P. J., L. S. Wise, R. Berkowitz, C. Wan, and C. S. Rubin. 1988. Insulin-like growth factor-I is an essential regulator of the differentiation of 3T3-L1 adipocytes J. Biol. Chem. 263:9402.
63. Ewton, D. Z., S. L. Roof, K. A. Magri, F. J. McWade, and J. R. Florini. 1994. IGF-II is more active than IGF-I in stimulating L6A1 myogenesis: greater mitogenic actions of IGF-I delay differentiation. J. Cell. Physiol. 16:277.
64. Florini, J. R., D. Z. Ewton, and S. L. Roof. 1991. IGF-I stimulates terminal myogenic differentiation by induction of myogenin gene expression. Mol. Endocrinol. 5:718.
65. Florini, J. R., K. Magri, D. Ewton, P. James, K. Grindstaff, and P. Rotwein. 1991. "Spontaneous" differentiation of skeletal myoblasts is controlled by autocrine secretion of insulin-like growth factor-II. J. Biol. Chem. 266:15917.
66. Montarras, D., C. Pinset, M.-C. Perez, J. Ilan, and F. Gros. 1993. Muscle differentiation: insulin-like growth factors as positive modulators of myogenic regulatory genes. C. R. Acad. Sci. III 316:1029.
67. Adams, D. O., and T. A. Hamilton. 1987. Molecular transductional mechanisms by which IFNγ and other signals regulate macrophage development. Immunol. Rev. 97:5.
68. Gaynor, R., K. Simon, and P. Koeffler. 1991. Expression of c-jun during macrophage differentiation of HL-60 cells. Blood 77:2618.
69. 3 receptor and other nonreceptor transcription factors. Mol. Endocrinol. 8:1593.
70. Monnier, D., A. L. Boutillier, P. Giraud, R. Chiu, D. Aunis, P. Feltz, J. Zwiller, and J. P. Loeffler. 1994. Insulin-like growth factor-I stimulates c-fos and c-jun transcription in PC12 cells. Mol. Cell. Endocrinol 104:139.